Clinical Trial Update: Alirocumab in Patients with Sepsis [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating Alirocumab in patients with sepsis has completed, focusing on safety and tolerability in this population.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• alirocumab (alirocumab)

Snippet

Sponsor: Jonathan Sevransky | Conditions: Sepsis | Phase 1 | Status: COMPLETED